FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113388205> ?p ?o ?g. }

• W2113388205 endingPage "788" @default.
• W2113388205 startingPage "780" @default.
• W2113388205 abstract "We monitored the mRNA expression profiles of peripheral blood cells during treatment with a TNF-alpha inhibitor, infliximab, in patients with RA. Using a DNA microarray analysis, we demonstrated a unique set of genes, with distinct baseline and post-treatment changes in expression between responders and non-responders to infliximab treatment.Using a customized low-density cDNA microarray with 747 genes and a reliable data collection system, we monitored the mRNA expression profiles of whole blood cells from 18 RA patients before and after the infusion of infliximab for up to 22 weeks. The clinical response to treatment with infliximab was determined using the ACR response criteria, the disease activity score of 28 joints (DAS28), and individual clinical parameters. The patients were classified as responders or non-responders based on their ACR50% response at 22 weeks.Approximately 15% of the total genes were found to exhibit a >1.5-fold change, compared with their reference values, at one or more time points during the 22 weeks of infliximab therapy. The expression of inflammatory genes, such as IFN-related genes, was strongly correlated with the serum level of CRP and the DAS28. The increased expression of inflammatory genes in responders was normalized within 2 weeks and then remained at a normal level during the treatment period. In contrast, in the non-responders, the elevated expression at baseline, although it was significantly decreased at 2 weeks, returned to the baseline level after 14 weeks. In addition to inflammatory genes, we identified several groups of genes with distinct differences in expression between the responders and non-responders.Our results suggest that a customized low-density microarray is useful for monitoring mRNA expression profiles in peripheral blood cells, enabling us to identify a unique set of genes with differentially regulated expressions in responders and non-responders to a TNF inhibitor among patients with RA." @default.
• W2113388205 created "2016-06-24" @default.
• W2113388205 creator A5001413231 @default.
• W2113388205 creator A5016040529 @default.
• W2113388205 creator A5018698383 @default.
• W2113388205 creator A5020698786 @default.
• W2113388205 creator A5025310501 @default.
• W2113388205 creator A5027244234 @default.
• W2113388205 creator A5044712883 @default.
• W2113388205 creator A5046500459 @default.
• W2113388205 creator A5058629132 @default.
• W2113388205 creator A5068921102 @default.
• W2113388205 creator A5069645479 @default.
• W2113388205 creator A5083314956 @default.
• W2113388205 creator A5085221613 @default.
• W2113388205 date "2008-04-03" @default.
• W2113388205 modified "2023-10-04" @default.
• W2113388205 title "Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-α monoclonal antibody, infliximab" @default.
• W2113388205 cites W1573082422 @default.
• W2113388205 cites W1920379674 @default.
• W2113388205 cites W1965672602 @default.
• W2113388205 cites W1970156673 @default.
• W2113388205 cites W1978443926 @default.
• W2113388205 cites W1982364998 @default.
• W2113388205 cites W1985763670 @default.
• W2113388205 cites W1996389186 @default.
• W2113388205 cites W1996437423 @default.
• W2113388205 cites W1996472975 @default.
• W2113388205 cites W1999956368 @default.
• W2113388205 cites W2005923596 @default.
• W2113388205 cites W2005969372 @default.
• W2113388205 cites W2006547412 @default.
• W2113388205 cites W2008924465 @default.
• W2113388205 cites W2023102754 @default.
• W2113388205 cites W2023482280 @default.
• W2113388205 cites W2050154180 @default.
• W2113388205 cites W2050390987 @default.
• W2113388205 cites W2053246945 @default.
• W2113388205 cites W2053320649 @default.
• W2113388205 cites W2058489635 @default.
• W2113388205 cites W2060943696 @default.
• W2113388205 cites W2066291585 @default.
• W2113388205 cites W2074080905 @default.
• W2113388205 cites W2074277198 @default.
• W2113388205 cites W2075700713 @default.
• W2113388205 cites W2081734937 @default.
• W2113388205 cites W2097148639 @default.
• W2113388205 cites W2099659190 @default.
• W2113388205 cites W2100668965 @default.
• W2113388205 cites W2106273198 @default.
• W2113388205 cites W2110177517 @default.
• W2113388205 cites W2112251186 @default.
• W2113388205 cites W2113099825 @default.
• W2113388205 cites W2113299113 @default.
• W2113388205 cites W2113990193 @default.
• W2113388205 cites W2116843833 @default.
• W2113388205 cites W2130631271 @default.
• W2113388205 cites W2134714663 @default.
• W2113388205 cites W2137947798 @default.
• W2113388205 cites W2145160598 @default.
• W2113388205 cites W2149280513 @default.
• W2113388205 cites W2152507275 @default.
• W2113388205 cites W2157816493 @default.
• W2113388205 cites W2159106700 @default.
• W2113388205 cites W2163322743 @default.
• W2113388205 cites W2164138937 @default.
• W2113388205 cites W2167385753 @default.
• W2113388205 cites W2168888135 @default.
• W2113388205 cites W2319957449 @default.
• W2113388205 cites W4233851404 @default.
• W2113388205 cites W4243975432 @default.
• W2113388205 cites W4244976211 @default.
• W2113388205 doi "https://doi.org/10.1093/rheumatology/ken083" @default.
• W2113388205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18388148" @default.
• W2113388205 hasPublicationYear "2008" @default.
• W2113388205 type Work @default.
• W2113388205 sameAs 2113388205 @default.
• W2113388205 citedByCount "81" @default.
• W2113388205 countsByYear W21133882052012 @default.
• W2113388205 countsByYear W21133882052013 @default.
• W2113388205 countsByYear W21133882052014 @default.
• W2113388205 countsByYear W21133882052015 @default.
• W2113388205 countsByYear W21133882052016 @default.
• W2113388205 countsByYear W21133882052017 @default.
• W2113388205 countsByYear W21133882052018 @default.
• W2113388205 countsByYear W21133882052019 @default.
• W2113388205 countsByYear W21133882052020 @default.
• W2113388205 countsByYear W21133882052021 @default.
• W2113388205 countsByYear W21133882052022 @default.
• W2113388205 countsByYear W21133882052023 @default.
• W2113388205 crossrefType "journal-article" @default.
• W2113388205 hasAuthorship W2113388205A5001413231 @default.
• W2113388205 hasAuthorship W2113388205A5016040529 @default.
• W2113388205 hasAuthorship W2113388205A5018698383 @default.
• W2113388205 hasAuthorship W2113388205A5020698786 @default.
• W2113388205 hasAuthorship W2113388205A5025310501 @default.
• W2113388205 hasAuthorship W2113388205A5027244234 @default.
• W2113388205 hasAuthorship W2113388205A5044712883 @default.

• next